Skip to content

management of immature cataract (timira/ Motiyabind ) with triphaladi compound and elaneer kuzhambu anjana and Anti- Advanced Glycation End product effect of these drugs

Further study on evaluation of anti cataract effect of Triphaladi Compound Capsule and Elaneer Kuzhambu Anjana in Senile Immature cataract w.s.r. Timira and In Vitro analysis of Anti- AGE (Advanced Glycation End product) activity of test drugs

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2016/03/006708
Enrollment
103
Registered
2016-03-04
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients having Senile Immature Cataract

Interventions

Intervention1: Triphaladi Compound Capsule as internal medicine and Elaneer kuzhambu Anjana for Local Application: Group A â?? Patients in the group will receive Triphaladi Compound Capsule as interna

Sponsors

Institute for Post Graduate Teaching Research in Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Men and women 20 in each arm who meet the diagnostic standards of Immature Cataract 2. aged between 35-60 years of age are included in this study.

Exclusion criteria

Exclusion criteria: Subjects who will be suffering from- 1. Congenital Cataract 2. Mature and hyper mature Cataract 3. Glaucoma 4. Diabetic Retinopathy 5. Macular degeneration 6. Retinitis pigmentosa 7. Whose RBS and Blood Pressure will be not within normal limits 8. Who will be under steroid treatment & or any kind of Immunosuppressive therapy or 9. Under any Cataract inducing medication will be excluded from this study.

Design outcomes

Primary

MeasureTime frame
1.To evaluate various Ayurvedic treatment for cataract in practice at P.G. centres institutions of India. 2.To assess the efficacy of test drugs Elaneer Kuzhambu Anjana and Triphaladi compound capsule and chakshushya regimen alone in the management of senile immature cataract. 3.To evaluate In Vitro Anti- AGE (Advanced Glycation End product) activity of these test drugs. Timepoint: Till May-2017

Secondary

MeasureTime frame
4.To evaluate the response of trial drugs on participants having different Prakruti and different types of morphological forms of cataract.Timepoint: Till May-2017

Countries

India

Contacts

Public ContactDr Hitesh Bhati

IPGT AND RA, G.A.U. JAMNAGAR

bhatrajma2008@gmail.com7600901848

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026